P4HA1 and other ECM-related enzymes have been associated to higher tumor aggressiveness in different cancer models and its expression is transcriptionally controlled by HIF-1 (Stegen et al, 2019; Xiong et al, 2018). Here, P4HA1 is linked to neoplasm.